Vagus Nerve Stimulators Market is estimated to be valued at USD 3782.32 Million with CAGR of 9.0% by 2026 | Industry Size, Major Share, Trends, Growth, Components, Application, Logistics, Global Market Key Players and Regional Forecast

Global Vagus Nerve Stimulators Market, by Product Type (Implantable Devices and External Devices), By Application (Epilepsy, Depression, Cluster Headache & Migraine, and Others), By Distribution Channel (Hospital, Specialty Pharmacy, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 445.1 Mn in 2018, and is projected to exhibit a CAGR of 9.0% during the forecast period (2018–2026).

Get Sample PDF Brochure with Impact of COVID19: https://www.coherentmarketinsights.com/insight/request-sample/2514

Increasing approval and launch of new vagus nerve stimulators is expected to support global vagus nerve stimulators market growth over the forecast period. For instance, in November 2018, electroCore, Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for an expanded label for gammaCore non-invasive vagus nerve stimulator (nVNS) therapy for adjunctive use for the preventive treatment of cluster headache in adult patients.

Apply Promo Code “STAYHOME” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/2514

In January 2018, the company received 510(k) clearance the same product as an acute treatment of pain associated with migraine in adult patients In October, 2018 LivaNova plc. received the U.S. Food and Drug Administration approval for its latest vagus nerve stimulation therapy (‘VNS Therapy’) System, which consists of the SenTiva implantable generator and the next-generation VNS Therapy Programming System for the treatment of patients with drug-resistant epilepsy. Key players in the market are indulged in robust research and development activities for the development of novel vagus nerve stimulation therapies. Various key players have their vagus nerve stimulators in late phase clinical trial, which are expected to get approval in the near future. Hence, presence of such robust pipeline of new vagus nerve stimulators is expected to drastically drive the vagus nerve stimulators market growth over the forecast period. For instance, in October 2018, SetPoint Medical announced the completion of enrollment in the U.S. Food and Drug Administration (FDA) pilot Investigational Device Exemption (IDE) study, evaluating its proprietary bioelectronic device to treat patients with drug-refractory rheumatoid arthritis (RA).

Browse 35 Market Data Tables and 31 Figures spread through 160 Pages and in-depth TOC on Global Vagus Nerve Stimulators Market by Product Type (Implantable Devices, and External Devices), by Application (Epilepsy, Depression, Cluster Headache & Migraine, and Others), by Distribution Channel (Hospital, Specialty Pharmacy, and Others), by Distribution Channel (Hospital, Retail Pharmacy, and Online Pharmacy) and Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) – Global Forecast to 2026

To know the latest trends and insights prevalent in the Vagus Nerve Stimulators market press release, click the link below: https://www.coherentmarketinsights.com/press-release/vagus-nerve-stimulators-market-to-surpass-us-8872-mn-threshold-by-2026-1303

Furthermore, key players in the market are involved in expanding its manufacturing capabilities in order to expand production of vagus nerve stimulators and fulfill its demand in the market. For instance, in November 2018, electroCore, Inc. expanded its manufacturing capability by establishing a new design, development, and manufacturing facility to fulfill increasing demand for its gammaCore non-invasive vagus nerve stimulator product. The 13,640-square-foot office and manufacturing facility is located at Forge Way Business Center in Rockaway, New Jersey, U.S.

Special Requirements?
We value your investment and offer customization as per your requirements.

Share your precise requirements @ https://www.coherentmarketinsights.com/insight/request-customization/2514

Key Takeaways of the Vagus Nerve Stimulators Market:

• The global vagus nerve stimulators market is expected to exhibit a CAGR of 9.0% during the forecast period (2018 – 2026), owing to frequent product launches and approvals, and robust pipeline of novel vagus nerve stimulators.
• North America vagus nerve stimulators market is expected to be a lucrative market and U.S. is expected to hold dominant position in global vagus nerve stimulators market, owing to presence of key players and frequent research and development activities to develop and launch novel vagus nerve stimulators in the region. For instance, electroCore, Inc., SetPoint Medical Corporation, MicroTransponder, Inc., and Nervana, LLC. are some U.S.-based players involved in development and sale of novel vagus nerve stimulators for different indications
• Asia Pacific vagus nerve stimulators market is expected to show significant growth over the forecast period, owing to approval and launch of novel product in the region. For instance, in 2016, Beijing PINS Medical Co., Ltd. received China Food and Drug Administration (CFDA) approvals for both adult and children models of vagus nerve stimulation devices.
• Major players operating in the vagus nerve stimulators market include electroCore, Inc., LivaNova, PLC, SetPoint Medical Corporation, MicroTransponder, Inc., Beijing PINS Medical Co., Ltd., Parasym Ltd., Nervana, LLC, and tVNS Technologies GmbH.

Other Related Reports:

Neurology Devices Market, By Device Type (CSF Management devices (CSF Shunt Devices, CSF Drainage Devices), Interventional Neurology Devices (Neuro thromobectomy, Cerebral Balloon Angioplasty & Stents, Aneurysm Coiling, Support Devices), Neuro-surgery Devices (Neuro-endoscopes, Sterotactic- Systems, Ultrasonic- Aspirators, Aneurysm Clips), Neuro-stimulation Devices (Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Gastric Nerve Stimulation)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Agrica) – Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027

Neuromodulation Devices Market, By Device Type (Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices), By Application (Pain Management, Neurological and Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management, Incontinence Management, Others), By End User (Hospitals, Specialty Clinics, Ambulatory Centers, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) – Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027

Electrical Stimulation Devices Market, by Device (Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Vagus Nerve Stimulation Devices, Sacral Nerve Stimulation Devices, Gastric Electric Stimulation Devices, Transcutaneous electrical nerve Stimulation Devices, Neuromuscular Electrical Stimulation Devices, Cranial Electrical Stimulation Device, and Other Electrical Stimulation Devices), by Application (Pain Management, Neurological and Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management, Incontinence Management, and Others), by End User (Hospitals, Specialty Clinics, Ambulatory Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Global Industry Insights, and Forecast till 2026

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at contact@cdnnewswire.com.